TrialCancer medicine2023

A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone: SARC024 trial results.

Steven Attia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.